These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 8816981)

  • 21. Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children.
    Yamamoto AM; Deschamps I; Garchon HJ; Roussely H; Moreau N; Beaurain G; Robert JJ; Bach JF
    J Autoimmun; 1998 Dec; 11(6):643-50. PubMed ID: 9878086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevalence and predictive value of GAD65 autoantibodies and their correlation with HLA DR-DQ genotypes in children with type-1 diabetes].
    Hermann R; Gombos Z; Gyürüs E; Soltész G
    Orv Hetil; 2003 Feb; 144(8):355-60. PubMed ID: 12666382
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sensitivity at diagnosis of combined beta-cell autoantibodies in insulin-dependent diabetic children. French Registry of IDDM in Children Study Group.
    Ongagna JC; Levy-Marchal C
    Diabetes Metab; 1997 Apr; 23(2):155-60. PubMed ID: 9137905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transmission of high-risk HLA-DQB1 alleles in Chilean type 1 diabetic patients and their parents: stratification by the presence of ICA or GAD65 autoantibodies.
    Pérez-Bravo F; Santos JL; Carrasco E; Calvillán M; Albala C; Puig-Domingo M; Piquer S; De Leiva A
    Autoimmunity; 2001; 33(4):285-91. PubMed ID: 11683403
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delay of type I diabetes in high risk, first degree relatives by parenteral antigen administration: the Schwabing Insulin Prophylaxis Pilot Trial.
    Füchtenbusch M; Rabl W; Grassl B; Bachmann W; Standl E; Ziegler AG
    Diabetologia; 1998 May; 41(5):536-41. PubMed ID: 9628270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Do glutamic acid decarboxylase antibodies improve the prediction of IDDM in first-degree relatives at risk for IDDM?
    Schmidli RS; Colman PG; Harrison LC
    J Autoimmun; 1994 Dec; 7(6):873-9. PubMed ID: 7888043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coincidence of high antiislet and antithyroid autoantibody titles in first-degree relatives of patients with type 1 diabetes.
    Sougioultzoglou F; Falorni A; Kassi G; Brozzetti A; Karamitsos D; Koliakos GG
    Exp Clin Endocrinol Diabetes; 2005 Feb; 113(2):85-9. PubMed ID: 15772899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic and genetic markers in insulin-dependent diabetes mellitus (type 1) in an Argentine population.
    Krochik AG; Mazza CS; Valdez SN; Stumpo RR; Papouchado ML; Iacono RF; Cardoso Landaburu AC; Sica MP; Ozuna B; Poskus E
    Medicina (B Aires); 2001; 61(3):279-83. PubMed ID: 11474874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneity of islet cell cytoplasmic antibodies and autoantibodies to glutamate decarboxylase in relatives of patients with type 1 (insulin-dependent) diabetes.
    Bergerot I; Souchier C; Thivolet C
    C R Acad Sci III; 1993 Nov; 316(11):1368-73. PubMed ID: 8087616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial clustering of beta-cell autoimmunity in initially non-diabetic children.
    Kukko M; Toivonen A; Kupila A; Korhonen S; Keskinen P; Veijola R; Virtanen SM; Ilonen J; Simell O; Knip M
    Diabetes Metab Res Rev; 2006; 22(1):53-8. PubMed ID: 16100734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of islet-specific autoantibodies in Japanese patients with insulin-dependent diabetes mellitus: a comparison between autoantibodies to glutamic acid decarboxylase, autoantibodies to 64 kDa islet cell protein and islet cell antibodies.
    Kawasaki E; Takino H; Yano M; Uotani S; Matsumoto K; Yamaguchi Y; Akazawa S; Nagataki S
    J Autoimmun; 1994 Dec; 7(6):791-802. PubMed ID: 7888036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children.
    Savola K; Sabbah E; Kulmala P; Vähäsalo P; Ilonen J; Knip M
    Diabetologia; 1998 Nov; 41(11):1293-7. PubMed ID: 9833935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibodies to glutamic acid decarboxylase in Australian children with insulin-dependent diabetes mellitus and their first-degree relatives.
    Chen QY; Rowley MJ; Byrne GC; Jones TW; Tuomi T; Knowles WJ; Zimmet PZ; Mackay IR
    Pediatr Res; 1993 Dec; 34(6):785-90. PubMed ID: 8108194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibodies in type 1 diabetes.
    Taplin CE; Barker JM
    Autoimmunity; 2008 Feb; 41(1):11-8. PubMed ID: 18176860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disease-associated autoantibodies and HLA-DQB1 genotypes in children with newly diagnosed insulin-dependent diabetes mellitus (IDDM). The Childhood Diabetes in Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Reijonen H; Veijola R; Vähäsalo P; Karjalainen J; Ilonen J; Akerblom HK; Knip M
    Clin Exp Immunol; 1999 Apr; 116(1):78-83. PubMed ID: 10209508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytoplasmic islet cell antibodies remain valuable in defining risk of progression to type 1 diabetes in subjects with other islet autoantibodies.
    Pietropaolo M; Yu S; Libman IM; Pietropaolo SL; Riley K; LaPorte RE; Drash AL; Mazumdar S; Trucco M; Becker DJ
    Pediatr Diabetes; 2005 Dec; 6(4):184-92. PubMed ID: 16390386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ICA512(IA-2) epitope specific assays distinguish transient from diabetes associated autoantibodies.
    Miao D; Yu L; Tiberti C; Cuthbertson DD; Rewers M; di Mario U; Eisenbarth GS; Dotta F
    J Autoimmun; 2002 Mar; 18(2):191-6. PubMed ID: 11908951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple antibody status in type 1 diabetic patients and subjects at various risk with islet-cell antibodies.
    Maugendre D; Chaillous L; Rohmer V; Lecomte P; Marechaud R; Saï P; Marre M; Charbonnel B; Allannic H; Delamaire M
    Diabetes Metab; 1997 Sep; 23(4):320-6. PubMed ID: 9342546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stability of autoantibodies and their relation to genetic and metabolic markers of Type I diabetes in initially unaffected schoolchildren.
    Kulmala P; Rahko J; Savola K; Vähäsalo P; Veijola R; Sjöroos M; Reunanen A; Ilonen J; Knip M
    Diabetologia; 2000 Apr; 43(4):457-64. PubMed ID: 10819239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.